Back to Journals » Clinical Ophthalmology » Volume 12

Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications [Corrigendum]

Authors Shen J, Goodkin ML, Tong W, Attar M

Received 12 July 2018

Accepted for publication 12 July 2018

Published 17 August 2018 Volume 2018:12 Pages 1471—1472

DOI https://doi.org/10.2147/OPTH.S179994


Shen J, Goodkin ML, Tong W, Attar M. Clin Ophthalmol. 2017;11:1761–1767.

On page 1765, Clinical correlation with evidence for use of bimatoprost twice daily in humans section, second column, last line, “−5.4 to −5.6 mm Hg” should have read “−5.4 to −6.0 mm Hg”.

Read the original article

Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications [Corrigendum]

Shen J, Goodkin ML, Tong W, Attar M. Clin Ophthalmol. 2017;11:1761–1767.

On page 1765, Clinical correlation with evidence for use of bimatoprost twice daily in humans section, second column, last line, “−5.4 to −5.6 mm Hg” should have read “−5.4 to −6.0 mm Hg”.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]